Best among the key molecular diagnostic markers of bacterial vaginosis.

Tongyang Deng, Xiangquan Song, Qiumei Liao, Ying Zheng, Hong Sun, Lianzhen Zhang, Xuejia Chen
Author Information
  1. Tongyang Deng: Department of Laboratory Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, People's Republic of China.
  2. Xiangquan Song: Department of Laboratory, Hangzhou Xihu District Hospital of Traditional Chinese and Western Medicine, Hangzhou, People's Republic of China.
  3. Qiumei Liao: Department of Rehabilitation Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, People's Republic of China. 675646034@qq.com.
  4. Ying Zheng: Department of Obstetrics and Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou, People's Republic of China.
  5. Hong Sun: Department of Laboratory Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, People's Republic of China.
  6. Lianzhen Zhang: Department of Laboratory Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, People's Republic of China.
  7. Xuejia Chen: Department of Obstetrics and Gynecology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, People's Republic of China. dty007005@163.com. ORCID

Abstract

To assess bacterial vaginosis (BV)-related primary molecular diagnostic markers of Lactobacillus crispatus, Gardnerella vaginalis, Fannyhessea vaginae, bacterial vaginosis-associated bacteria 2 (BVAB-2), Megasphaera-1 and Megasphaera-2 and to discover molecular diagnostic indicators of BV with the most economic value for the efficient diagnosis of BV.All vaginal secretion specimens, including 122 BV-positive cases and 130 BV-negative controls were collected. First, quantitative polymerase chain reaction (PCR) was used to determine the levels of above the six bacteria. Then, the detection rates, sensitivity, specificity, diagnostic threshold, and receiver operating characteristic (ROC) curve were compared. Megasphaera-1 and Megasphaera-2 were detected in the BV-positive group, with a low detection rate of 35.25% and 19.67% respectively. The sensitivity and specificity of the above four bacteria were 95.90%/72.31%, 82.79%/92.48%, 72.13%/95.38%, and 56.56%/94.62% respectively, using the cut-off value for the diagnosis of BV. When combinations of L. crispatus with G. vaginalis, F. vaginae, and BVAB-2 were performed respectively, their sensitivity and specificity were 99.29%/97.79%, 98.86%/98.72%, and 98.22%/98.51% in sequence.It is difficult to diagnose BV using only one species, however, combinations of L. crispatus with G. vaginalis or F. vaginae showed a better diagnostic effect, particularly with the combination of L. crispatus and G. vaginalis.

Keywords

References

  1. APMIS. 2005 May;113(5):305-16 [PMID: 16011656]
  2. BMC Infect Dis. 2007 Nov 07;7:128 [PMID: 17986357]
  3. J Clin Microbiol. 2012 Jul;50(7):2321-9 [PMID: 22535982]
  4. J Clin Microbiol. 1991 Feb;29(2):297-301 [PMID: 1706728]
  5. J Infect Dis. 2006 Sep 15;194(6):828-36 [PMID: 16941351]
  6. Obstet Gynecol. 2004 Aug;104(2):267-72 [PMID: 15291998]
  7. J Clin Microbiol. 2018 Aug 27;56(9): [PMID: 29769280]
  8. Front Cell Infect Microbiol. 2020 Aug 11;10:354 [PMID: 32850469]
  9. PLoS One. 2014 Aug 22;9(8):e105998 [PMID: 25148517]
  10. Bioengineered. 2022 Feb;13(2):2981-2991 [PMID: 35038957]
  11. Antibiotics (Basel). 2021 Jun 15;10(6): [PMID: 34203908]
  12. Cochrane Database Syst Rev. 2009 Jul 08;(3):CD006055 [PMID: 19588379]
  13. N Engl J Med. 2005 Nov 3;353(18):1899-911 [PMID: 16267321]
  14. Int J Syst Evol Microbiol. 2019 Mar;69(3):679-687 [PMID: 30648938]
  15. Lancet. 2013 Jan 19;381(9862):223-34 [PMID: 23158883]
  16. Am J Epidemiol. 2005 Sep 15;162(6):585-90 [PMID: 16093289]
  17. J Infect Dis. 2010 Dec 15;202(12):1907-15 [PMID: 21067371]
  18. 3 Biotech. 2013 Apr;3(2):97-107 [PMID: 28324565]
  19. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):203-10 [PMID: 18520679]
  20. Res Microbiol. 2017 Nov - Dec;168(9-10):782-792 [PMID: 28435139]
  21. BMJ. 1994 Jan 29;308(6924):295-8 [PMID: 8124116]
  22. Microbiol Spectr. 2023 Aug 17;11(4):e0467622 [PMID: 37347202]
  23. J Clin Microbiol. 2010 May;48(5):1812-9 [PMID: 20305015]
  24. BMC Infect Dis. 2011 Jul 19;11:200 [PMID: 21771337]
  25. J Clin Microbiol. 1983 Jul;18(1):170-7 [PMID: 6193137]
  26. J Clin Microbiol. 2005 Sep;43(9):4607-12 [PMID: 16145114]
  27. J Clin Microbiol. 1982 Jan;15(1):141-7 [PMID: 6764766]
  28. Ann Intern Med. 2008 Jul 1;149(1):20-8 [PMID: 18591634]
  29. Sex Transm Infect. 2017 Sep;93(6):410-415 [PMID: 28143901]
  30. Expert Opin Pharmacother. 2014 Apr;15(5):645-57 [PMID: 24579850]
  31. Clin Microbiol Rev. 2016 Apr;29(2):223-38 [PMID: 26864580]
  32. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7 [PMID: 20534435]
  33. BJOG. 2006 Dec;113(12):1419-25 [PMID: 17010117]
  34. J Infect Dev Ctries. 2011 May 28;5(5):353-60 [PMID: 21628811]
  35. BMC Microbiol. 2004 Apr 21;4:16 [PMID: 15102329]
  36. J Clin Microbiol. 2016 Apr;54(4):1017-24 [PMID: 26818677]
  37. Am J Obstet Gynecol. 1988 Apr;158(4):819-28 [PMID: 3259075]
  38. Clin Infect Dis. 2008 Jul 1;47(1):33-43 [PMID: 18513147]
  39. Front Microbiol. 2018 Aug 22;9:2007 [PMID: 30186281]
  40. J Clin Microbiol. 1989 Jun;27(6):1266-71 [PMID: 2473992]
  41. Obstet Gynecol. 1996 Oct;88(4 Pt 1):573-6 [PMID: 8841221]
  42. Am J Med. 1983 Jan;74(1):14-22 [PMID: 6600371]
  43. J Reprod Med. 2001 Sep;46(9):806-10 [PMID: 11584481]
  44. J Clin Microbiol. 2007 Oct;45(10):3270-6 [PMID: 17687006]
  45. Sex Transm Dis. 2019 May;46(5):304-311 [PMID: 30624309]
  46. Sex Transm Infect. 2002 Dec;78(6):413-5 [PMID: 12473800]

Grants

  1. No. LGC22H200014/This work was supported by the Basic Public Welfare Research Project of Zhejiang, China

Word Cloud

Created with Highcharts 10.0.0diagnosticBVcrispatusvaginalisvaginaebacterialvaginosismolecularbacteriasensitivityspecificityrespectivelyLGmarkersLactobacillusGardnerellaFannyhesseaBVAB-2Megasphaera-1Megasphaera-2valuediagnosisBV-positivedetectionusingcombinationsF98assess-relatedprimaryvaginosis-associated2discoverindicatorseconomicefficientAllvaginalsecretionspecimensincluding122cases130BV-negativecontrolscollectedFirstquantitativepolymerasechainreactionPCRuseddeterminelevelssixratesthresholdreceiveroperatingcharacteristicROCcurvecompareddetectedgrouplowrate3525%1967%four9590%/7231%8279%/9248%7213%/9538%5656%/9462%cut-offperformed9929%/9779%86%/9872%22%/9851%sequenceItdifficultdiagnoseonespecieshowevershowedbettereffectparticularlycombinationBestamongkeyBacterialMolecularmarker

Similar Articles

Cited By